Systemic delivery of fusogenic membrane glycoprotein-expressing neural stem cells to selectively kill tumor cells.
about
Combinatorial control of transgene expression by hypoxia-responsive promoter and microrna regulation for neural stem cell-based cancer therapy.Antitumor effects of CD40 ligand-expressing endothelial progenitor cells derived from human induced pluripotent stem cells in a metastatic breast cancer model.High-resolution chromosomal microarray analysis of early-stage human embryonic stem cells reveals an association between X chromosome instability and skewed X inactivationA Double-Switch Cell Fusion-Inducible Transgene Expression System for Neural Stem Cell-Based Antiglioma Gene Therapy.Directing and Potentiating Stem Cell-Mediated Angiogenesis and Tissue Repair by Cell Surface E-Selectin Coating.Uniparental disomy of the entire X chromosome in Turner syndrome patient-specific induced pluripotent stem cellsTargeted Inhibition of the miR-199a/214 Cluster by CRISPR Interference Augments the Tumor Tropism of Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells under Hypoxic Condition.Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy.Vesicular Stomatitis Virus G Glycoprotein and ATRA Enhanced Bystander Killing of Chemoresistant Leukemic Cells by Herpes Simplex Virus Thymidine Kinase/Ganciclovir.Mitomycin C-treated human-induced pluripotent stem cells as a safe delivery system of gold nanorods for targeted photothermal therapy of gastric cancer.Advances in Anticancer Protein Delivery Using Micro-/ Nanoparticles.Integrative Analysis of CRISPR/Cas9 Target Sites in the Human HBB Gene.Virus-Mimetic Fusogenic Exosomes for Direct Delivery of Integral Membrane Proteins to Target Cell Membranes.Yeast Actin-Related Protein ARP6 Negatively Regulates Agrobacterium-Mediated Transformation of Yeast CellTumor-homing cytotoxic human induced neural stem cells for cancer therapy.
P2860
Q33594142-ABBE6FFB-12FD-4630-826D-E785749A8D4AQ33975595-F7A2EA53-8D4F-4652-9B8F-CC678168E98FQ34695148-E660CB7C-89F8-477A-8EEE-48ECBEB39245Q35620945-E0C8EFDA-2E10-4AA5-9BB0-F69C677B0178Q35996836-043E9056-2627-486C-98D0-0E94B65AD4EDQ36882709-EECD0425-E8F4-4546-A44F-8DDD97EFE0E7Q37443725-84AC1C4E-8591-4DDA-B803-3DBB903DEAC6Q37629088-079CABAE-CCC3-4AB2-BD6B-648E6A88AB92Q37684212-3A514CCC-DCF7-4DFB-B2E4-D7E65DEEC767Q38786696-54C1ED22-7378-46D8-8469-C634005B84EEQ39092873-9B298387-0D49-4F24-9D00-A7BB90EBB455Q39609159-28005CB5-4A41-44C3-8D44-8D5F196D1FAFQ40348381-D9D6387E-6AB3-4D1D-9901-20F348113E72Q42585013-172E7724-0DC7-4DF7-8AE8-5A8BCD6BBE87Q48329121-CEE5AAFC-8371-401C-A029-BB39871C5558
P2860
Systemic delivery of fusogenic membrane glycoprotein-expressing neural stem cells to selectively kill tumor cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systemic delivery of fusogenic ...... selectively kill tumor cells.
@en
Systemic delivery of fusogenic ...... selectively kill tumor cells.
@nl
type
label
Systemic delivery of fusogenic ...... selectively kill tumor cells.
@en
Systemic delivery of fusogenic ...... selectively kill tumor cells.
@nl
prefLabel
Systemic delivery of fusogenic ...... selectively kill tumor cells.
@en
Systemic delivery of fusogenic ...... selectively kill tumor cells.
@nl
P2093
P2860
P356
P1433
P1476
Systemic delivery of fusogenic ...... o selectively kill tumor cells
@en
P2093
Chunxiao Wu
Dang Hoang Lam
Jieming Zeng
Sal Lee Goh
Weimin Fan
Yovita Ida Purwanti
P2860
P304
P356
10.1038/MT.2013.123
P50
P577
2013-06-11T00:00:00Z